Search for: "Vitro Chemicals" Results 81 - 100 of 112
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2011, 1:17 pm by Brenda Fulmer
  In the Japanese patient featured in this medical report, the surgeons noted the presence of pseudotumors in the patient’s pelvis, thigh, and gluteal region, which were triggered by a breakdown in the chemical properties of the metallic surfaces of the patient’s hip implant. [read post]
23 Aug 2013, 11:19 am by Jason Rantanen
And they avoided anticipatory prior art during prosecution by asserting that the conditioned medium produced by two-dimensional cultures was inferior and chemically distinct from the conditioned medium produced by three-dimensional cultures. [read post]
28 Jun 2022, 2:53 am by MaxVal
Roche Seeks to Patent a Sensor Device U.S. patent application, US20220196632, discloses a sensor device for an in vitro diagnostics (IVD) analyzer that comprises sensors arranged in fluidic conduits. [read post]
23 Oct 2009, 4:12 pm
 The test results need not be Phase II (human trials), but rather may be from animal tests or in vitro research. [read post]
21 Jul 2008, 2:10 pm
The fifth – and newest – WG 3 work item, Guidance on physico-chemical characterization of engineered nano-objects for toxicologic assessment, will serve as a reference for characterizing nano-objects for toxicology testing. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
5 Feb 2020, 2:31 pm by Kluwer Patent blogger
” Will Aldgate in London be the location of the UPC’s central division in charge of chemical, pharmaceutical and life science sectors, somewhere in the future? [read post]
14 Nov 2011, 1:17 pm by Brenda Fulmer
  In the Japanese patient featured in this medical report, the surgeons noted the presence of pseudotumors in the patient’s pelvis, thigh, and gluteal region, which were triggered by a breakdown in the chemical properties of the metallic surfaces of the patient’s hip implant. [read post]
1 Dec 2007, 2:04 pm
Embryos in a Petri dish can't become people without substantial human assistance, nor are they even likely to become people if they are placed in a womb (most embryos created either in vitro or through sexual intercourse do not survive). [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
5 Dec 2010, 3:01 pm by Oliver G. Randl
However, during the opposition procedure […], the Appellant has submitted Annex 2, disclosing the results of in vitro and in vivo experiments investigating the neuroprotective activity of combined xenon an dexmedetomidine dosage. [read post]
6 May 2010, 4:12 pm by Bexis
  Thus, when used for its approved medical applications it has to be “chelated” to become chemically inert. [read post]
14 Feb 2010, 12:13 pm
Substantial equivalence is established with respect to intended use, design, energy used or delivered, materials, chemical composition, manufacturing process, performance, safety, effectiveness, labeling, biocompatibility, standards, and other characteristics, as applicable [read post]
10 Sep 2012, 7:28 pm by FDABlog HPM
After a full and reasoned discussion, FDA affirmed its chemical-structure based interpretation of the applicable statutory and regulatory provisions. [read post]
23 Nov 2010, 6:14 am by Schachtman
”  Those cases represent complex evidentiary displays that involved animal, in vitro, chemical analysis, and epidemiologic studies. [read post]
14 Feb 2010, 12:13 pm
Substantial equivalence is established with respect to intended use, design, energy used or delivered, materials, chemical composition, manufacturing process, performance, safety, effectiveness, labeling, biocompatibility, standards, and other characteristics, as applicable [read post]
2 Jan 2015, 4:52 am by Robin Shea
Kimberly Hartman, a paralegal for Dow Chemical, was terminated about six weeks after returning to work from FMLA leave. [read post]
10 Aug 2023, 7:13 am by Bradley Merrill Thompson
Since 1976, with only a few legislative adjustments, the definition of a medical device has been: (h)(1) The term “device” … means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is- … (B) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or… [read post]
13 Aug 2010, 1:25 pm
The following is a comprehensive description of the hemolytic uremic syndrome (HUS), its symptoms, and the complications and long-term risks associated with HUS. [read post]